QCG
HRMY icon

Quadrant Capital Group’s Harmony Biosciences HRMY Stock Holding History

Quadrant Capital Group’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-394
Closed -$11K – 1831
2026
Q1 		$11K Sell
394
-30
-7% -$984 ﹤0.01% 2168
2025
Q4 		$15.9K Hold
424
– – ﹤0.01% 2075
2025
Q3 		$11.7K Buy
+424
New +$14.6K ﹤0.01% 2117
2025
Q2 		– Sell
-2,703
Closed -$89.7K – 1911
2025
Q1 		$89.7K Buy
2,703
+2,395
+778% +$85.9K ﹤0.01% 1555
2024
Q4 		$10.6K Sell
308
-74
-19% -$2.54K ﹤0.01% 2108
2024
Q3 		$15.3K Hold
382
– – ﹤0.01% 2003
2024
Q2 		$11.5K Sell
382
-70
-15% -$2.1K ﹤0.01% 2071
2024
Q1 		$15.2K Sell
452
-570
-56% -$18.3K ﹤0.01% 1951
2023
Q4 		$33K Buy
1,022
+329
+47% +$9.18K ﹤0.01% 1585
2023
Q3 		$22.7K Sell
693
-16
-2% -$555 ﹤0.01% 1653
2023
Q2 		$24.9K Buy
+709
New +$24.5K ﹤0.01% 1606
2023
Q1 		– Sell
-286
Closed -$15.8K – 2750
2022
Q4 		$15.8K Buy
286
+194
+211% +$10.7K ﹤0.01% 1761
2022
Q3 		$4K Hold
92
– – ﹤0.01% 2208
2022
Q2 		$4K Buy
+92
New +$4.14K ﹤0.01% 2037

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quadrant Capital Group's HRMY Position: Q2 2026 in Review

Quadrant Capital Group sold out of Harmony Biosciences (HRMY) in Q2 2026, closing a stake of 394 shares — an estimated $11K sold.

Quadrant Capital Group first reported a position in HRMY in Q2 2022 and held it in 14 quarters. The position peaked at $89.7K in Q1 2025. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Quadrant Capital Group reported no remaining Harmony Biosciences position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 394 Harmony Biosciences shares in Q2 2026, an estimated $11K.
  • Quadrant Capital Group first reported a position in Harmony Biosciences in Q2 2022 and held it in 14 quarters.
  • Quadrant Capital Group's Harmony Biosciences position peaked at $89.7K in Q1 2025.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.